FILTER
FILTERED INTERVIEW RESULTS
Kendalle Burlin O’Connell
CEO AND PRESIDENT, MASSBIO
"In 2023, Massachusetts made up just shy of 15% of the national drug development pipeline and approximately 7% of the global drug development pipeline."
Andrea Confetti and Roberto Fanelli
EXCLUSIVE SYNTHESIS BU LEADER (AC) & CATALOGUE APIS BU LEADER (RF), DIPHARMA FRANCIS
"Dipharma is proud to have been reliably serving the life sciences industry for decades and will continue to do so for many years to come."
Mark Bristow
CEO, BARRICK GOLD
"We plan to double our copper production by the end of the decade. There remains significant upside potential in the gold industry, and the copper operations are strategic and additive to that."
Trevor P. Castor
PRESIDENT & CEO, APHIOS
"Aphios, which means virus-free, has the core mission to not only contain viruses but also to treat underlying infectious diseases."
Milton Boyer and David Stevens
CEO (MB) & CCO (DS), KINDEVA DRUG DELIVERY
"A shift in pharma’s pipeline catalyzes a need for changes to CDMOs’ capacity."
Eric Smith
MANAGING DIRECTOR, CEMENTATION AMERICAS
"Pricing variability has made mining companies somewhat hesitant to invest in capital projects, despite favorable commodity prices."
Paolo Paissoni
DIRECTOR OF INNOVATION AND BUSINESS DEVELOPMENT, PROCOS SPA
"We are currently building a new workshop in which we are specifically going to add small-scale lines to support clinical trial supply and generic product manufacturing."
Misael Cabrera
DIRECTOR, SCHOOL OF MINING AND MINERAL RESOURCES, UNIVERSITY OF ARIZONA
"By producing well-rounded professionals, we aim to address the complexities of modern mining and promote responsible practices in the industry."
Louis P. Kassa III
PRESIDENT AND CEO, PENNSYLVANIA BIOTECHNOLOGY CENTER (PABC)
"We want scientists to focus on science, and we offer them the equipment and services so they can do that."
Debbie Hart
PRESIDENT, BIONJ
"We used our voice to educate on the value of medical innovation and boasted the strength of New Jersey’s vibrant ecosystem, which was responsible for more than 50% of all novel FDA approvals in 2023."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
USA Mining 2025-26 - Pre-release
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.
USA Mining 2025-26 pre-release is a snapshot capturing insights from over 70 executives and decision-makers across the value chain and from coast to coast, sharing not only how the industry is changing, but also where it is heading next.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
